Using RNAse protection, we have made quantitative measurements of erythropoietin (EPO) mRNA in liver and kidneys of developing rats (days 1-54), to determine the relative contribution of both organs to the total EPO mRNA, to monitor changes which occur with development, and to compare the hypoxia-induced accumulation of EPO mRNA with the changes in serum EPO concentrations. To determine whether developmental and organ-specific responsiveness is related to the type of hypoxic stimulus, normobaric hypoxia was compared with exposure to carbon monoxide (functional anemia).
Introduction
Erythropoietin (EPO)' is a glycoprotein hormone that is produced in inverse relationship to blood oxygen content and determines the rate ofred cell formation. The sites ofEPO production were originally deduced from the results of organ ablation studies and more recently from the distribution of EPO mRNA. Although these studies have firmly established the liver and the kidneys as production sites for EPO, discrepancies exist and the relative importance of each organ has not been determined unequivocally.
Organ ablation studies have revealed that in adult animals the increase in serum EPO levels in response to hypobaric hypoxia is reduced by -80-90% after bilateral nephrectomy (1) (2) (3) , the remaining EPO formation being abolished when nephrectomy is combined with subtotal hepatectomy (4) . In fetal and neonatal animals, however, bilateral nephrectomy was found to have little or no effect on EPO formation, whereas hepatectomy almost completely prevented an increase in serum EPO concentrations under hypoxia (5) (6) (7) (8) . From a gradual change in the effect of nephrectomy and/or hepatectomy on EPO formation during development it was inferred that in sheep a shift ofEPO production from liver to kidney is initiated during late gestation, with a hepatic contribution to EPO production of 70% around birth (9) . In rats, moreover, the kidneys appeared to play no or little role in EPO formation for up to two weeks after birth, thereafter gradually gaining increasing importance (2, 3, 10) .
Detection of EPO mRNA by Northern blotting of extracts from different organs confirmed liver and kidney as the sites of EPO gene expression (I 1, 12). In adult animals the abundance of EPO mRNA in kidneys was much higher than that in liver (1 1, 12) . Furthermore, in a recent study Koury et al. measured EPO mRNA levels in pooled extracts of kidneys and livers from developing normal and anemic mice using both Northern blotting and RNAse protection assay (13) . They found the proportion of EPO mRNA in the liver decreasing with age, but, in contrast to what may be anticipated from the organ ablation studies, they observed that the kidneys contain most EPO mRNA soon after they become macroscopically identifiable, i.e., during late gestation and all stages of postnatal development.
Several possibilities could explain this apparent discrepancy between the ablation studies and the quantitative analysis of EPO mRNA with regard to the role of the liver in EPO formation. Thus it is possible that EPO formation after nephrectomy and/or hepatectomy may not accurately reflect the situation in intact animals. Furthermore, the role of the liver for EPO formation may be species specific and be of less importance in mice than in rats, goats, or sheep, or may depend on the kind of stimulus used and be less significant in anemia than in hypoxic hypoxia. Alternatively, the findings may indicate that the relationship between EPO production rates and EPO mRNA content varies between liver and kidney, i.e., that hepatic EPO mRNA is more efficiently translated than renal EPO mRNA.
The respective ability of liver and kidneys to produce EPO and the responsiveness of both organs to different stimuli appears of major importance not only for the regulation of erythropoiesis around birth, but may also have implications for EPO formation under conditions of compromised kidney function as in chronic renal disease. We have therefore addressed the above possibilities by studying the age dependence ofEPO gene expression in rat kidneys and liver under basal conditions and following the exposure to normobaric (hypoxic) hypoxia and carbon monoxide (functional anemia). Both stimuli were applied for a short period of four hours to allow measurements at precisely timed and closely spaced points during the early postnatal phase and to avoid possible confounding effects from adaptive processes which have been observed with more prolonged exposure to hypoxic hypoxia (14, 15) . To investigate if the duration of stimulation is of central importance in determining organ-specific responsiveness, additional experiments were performed on adult animals studied after three days of repetitive bleeding. The rat was chosen as experimental animal to enable a direct comparison with the evidence available from organ ablation studies. To further judge the significance of these organ ablation studies for EPO formation in the intact organism, we have also investigated the effect of nephrectomy on hepatic EPO gene expression. To allow a direct comparison between circulating EPO levels and EPO mRNA, serum EPO levels were determined by radioimmunoassay and EPO mRNA concentration was measured in kidneys and liver from individual animals using a quantitative RNAse protection assay. Experiments with nephrectomized animals. Bilateral nephrectomies were carried out in adult rats (6-7 wk old) under light methofane anesthesia through bilateral flank incisions. 7 h after the operation nephrectomized rats were exposed for 4 h to 0.1% carbon monoxide together with sham-operated control animals. 24 h after the last phlebotomy (anemic animals), within 15 min after the end ofcarbon monoxide exposure, and within 30 min after the end of hypoxic hypoxia, animals were killed by decapitation (age 1-14 d) followed by direct collection of blood or by cervical dislocation (age 28-54 d), after which blood was collected from the abdominal aorta. Kidneys and livers were removed and after determination of wet weight kidneys were completely and livers were in part or completely homogenized in guanidine thiocyanate (4 M) containing sarcosyl (0.5%), EDTA (10 mM), sodium citrate (25 mM), and mercaptoethanol (700 mM). Different amounts ofguanidine thiocyanate were used to maintain a constant concentration of -0.04 g tissue per ml; except for the kidneys of l-d old animals, when the concentration was 0.02 g tissue per ml. After several determinations in earlier experiments demonstrated that the concentration of EPO mRNA is the same in all lobes of the liver (16) , weighed portions of the right lateral lobe were used in those experiments where only a portion of the liver was homogenized. Tissue homogenates were frozen at -80'C until preparation of RNA.
Methods
RNAse protection assay. RNAse protection assay was performed as described (17) . RNA was purified by centrifugation for 20 h at 33,000 rpm on a cesium chloride gradient (5.7 M CsCl and 100 mM EDTA).
After centrifugation RNA pellets were resuspended in 300 UI TE (10 mM Tris, 1 mM EDTA) containing 0.1% SDS, precipitated with 3 M sodium acetate (0.1 vol) and ethanol (3 vol) , and stored at -800C before analysis.
The rat EPO probe was a PstI/SacI fragment containing 132 bp of exon V and -300 bp ofthe adjoining intron, inserted into pSP 64 for generation of RNA transcripts. Transcripts were continuously labelled with alpha 32P-GTP (410 Ci/mmol; Amersham International, Amersham, Bucks., UK). For hybridization aliquots of total RNA were dissolved in buffer (80% formamide, 40 mM piperazine-N,N-bis(2-ethane sulfonic acid), 400 mM sodium chloride, 1 mM EDTA pH 8) and the RNA concentrations determined by measurement of optical density at 260 nm. The concentration was adjusted to yield 50-,ul samples containing 100-150 ,g total RNA.
Hybridization was performed overnight at 60°C with 0.5-1.0 X 106 cpm radiolabelled EPO probe. RNAse digestion with RNAse A and TI was carried out at 20°C for 30 min and terminated by the addition of proteinase K and SDS before purification ofthe protected fragments by phenol/chloroform extraction and ethanol precipitation and electrophoresis on a denaturing 10% polyacrylamide gel.
Autoradiography of the dried gel was performed at -70°C. Protected EPO mRNA bands were excised from the dried gel and counting was performed using a flat-bed liquid scintillation counter (1205; Beta- plater', Pharmacia-Wallac OY, Turku, Finland). The number of counts per minute obtained from each EPO mRNA sample was divided by the quantity of total RNA analyzed to yield the EPO mRNA abundance (EPO mRNA/,ug total RNA). An external standard, consisting of pooled RNA extracted from the kidneys of severely anemic rats, was used to correct for any difference in quantitation arising between assays. 20,ug ofthe standard was run with each assay and sample EPO mRNA levels were expressed relative to the EPO mRNA count in the corresponding standard, which was assigned an arbitrary value of 1.0. In earlier experiments the results of duplicate RNAse protection assays of RNA prepared from the same organ showed a high degree of reproducibility and assays ofdifferent concentrations ofRNA prepared from the same organ exhibited linearity ofthe assay overthe experimental range (18) .
The total organ quantity ofRNA in kidney and liver was calculated from the amount of RNA extracted from aliquots of homogenate derived from known weights of tissue. There was a reproducible linear relationship between the RNA yield and the weight of tissue homogenized.
EPO radioimmunoassay. Serum EPO concentrations were determined as described (19) with the use of a rabbit antiserum raised against pure recombinant human EPO and iodinated recombinant human EPO (Amersham) as tracer. A rat serum pool enriched in EPO was prepared by exposing donor animals to hypoxia and was used as standard after calibration against the II. International Reference Preparation by in vivo bioassay (19) . Student's unpaired t test was used for comparison of groups and analysis of variance to determine significance levels of linear regressions. P < 0.05 was considered significant.
Results
Body weight, kidney, and liver weight ofthe animals studied at different ages, the amount of total RNA extracted per gram tissue, and the estimates of the amount of total RNA in both organs are given in Table I . In both liver and kidneys the concentrations oftotal RNA declined slightly during development and at day 54 were 42% lower in liver and 36% lower in kidney than in neonatal animals. At each age level the amount oftotal RNA per gram tissue was about 2-fold higher in liver than in kidney, and considering the differences in organ weight, the liver contained approximately 5-to 8-fold more total RNA than both kidneys during the first three weeks and approximately 10-fold more on days 28 and 54.
Measurements ofserum erythropoietin concentrations. The serum EPO levels at the different ages under basal conditions and after exposure to normobaric hypoxia or carbon monoxide are given in Fig. 1 . Under basal conditions EPO levels were maximal one day after birth (62.6±19.2 mU/ml, mean±SE, n = 7) and thereafter declined about 3-fold to reach a level two weeks after birth that was similar to that of adults (17.7±5.5 mU/ml, mean±SE, n = 3). At all ages animals responded to both stimuli with an increase in EPO levels. The amplitude of this increase, however, was clearly age dependent, with 1 The total amount of EPO mRNA in liver and kidneys and the relative contribution of the liver to EPO formation in the whole animal are shown in Fig. 4 B and Table III . It can be seen that the liver accounts for a remarkably large proportion ofthe total EPO mRNA and contains the majority of EPO mRNA for the first three to four weeks in both stimulated and unstimulated rats. During this period, however, the predominance of the liver was most pronounced under basal conditions. Thus the liver accounts for more than 94% of EPO mRNA in unstimulated animals during the first three weeks, whereas under normobaric hypoxia and carbon monoxide, the hepatic contri- Fig. 4 and Methods). EPO mRNA concentrations per gram wet weight of tissue were calculated from the abundance of EPO mRNA per gram of total RNA (Fig. 4 A) and the concentrations of total RNA per gram wet weight of tissue (Table I) . Mean±SD; n = 7-8 for l-d old animals, 6 for 7-d old animals exposed to carbon monoxide, and 3 for all other groups.
1,278+511 mU/ml and 2,631±362 mU/ml, respectively (mean±SD, n = 5). The total organ EPO mRNA on day 4 was 157.7±42.8 in kidneys and 80.9±32.8 in livers (mean±SD); the resulting proportion of hepatic EPO mRNA in relation to the total EPO mRNA was 34.4±11.5% (mean±SD) and not significantly different from that following short-term exposure to hypoxic hypoxia or carbon monoxide. Experiments with nephrectomized animals. The amount of EPO mRNA and serum EPO levels in adult rats exposed to carbon monoxide 7 h after bilateral nephrectomy are shown in Fig. 5 . It can be seen that the serum EPO levels reached were only 17% ofthose reached in the sham-operated controls. However, hepatic EPO mRNA accumulation in the liver of nephrectomized animals was also significantly reduced to -55% of that observed in the sham-operated controls. Relationship oferythropoietin mRNA to serum erythropoietin concentrations during development. To facilitate comparison of EPO mRNA content with serum EPO concentration, the total EPO mRNA content (the sum of renal and hepatic EPO mRNA content) for stimulated and unstimulated animals at different ages was normalized to the body weight (Table III) . When expressed in this way, the total EPO mRNA in animals of a particular age was related linearly to the serum EPO concentration. This relationship was seen over a wide range of Fig. 6 . However, the slope of the regression was not the same for each age group and increased progressively during development, being approximately ninefold greater in 54-d-old animals than in 1-d old animals. Thus, when normalized for body weight, the total EPO mRNA content achieved under the most powerful stimulus was approximately constant with development (Table III) , whereas the corresponding serum EPO levels increased markedly (Fig. 1) . EPO mRNA/body weight (1/g) Figure 6 . Relationship between the total amount of EPO mRNA in the animals, i.e., the sum of renal and hepatic EPO 
I Discussion
A major control mechanism for EPO formation has been found to operate by modulation of EPO mRNA (1 1, 12, 20) and this investigation demonstrates significant alterations in the amount of EPO mRNA in rat kidneys and liver during development, which is basically in accordance with the age dependence ofthe effects ofbilateral nephrectomy and hepatectomy on EPO formation (2, 5, 6, 10) . In contrast to anemic mice, as recently shown by Koury et al. (13) , in the present study the hepatic proportion of EPO mRNA was considerable, accounting for the majority of EPO mRNA during early postnatal life and for about one-third ofEPO mRNA during adulthood (Fig. 4 B , Table III ). The predominance of the liver in neonatal and juvenile animals was found irrespective of whether the animals were stimulated or not and regardless of whether the stimulus was normobaric hypoxia or exposure to carbon monoxide. Irrespective of changes with age the hepatic proportion of the total EPO mRNA was in fact very similar under these two stimuli at 1, 14, and 54 days, and somewhat lower only at 7 and 28 days in the carbon monoxide group (Table III) . Furthermore, although these stimuli were applied for a short time only, the liver appears not to respond primarily in the early phase of hypoxia, since the hepatic contribution was also about one-third in adult animals with more prolonged reductions in hematocrit. Thus, despite the differences in the mode of limitation of oxygen delivery during normobaric hypoxia, exposure to carbon monoxide, or anemia, there was no striking difference between the relative sensitivity of liver and kidney to each stimulus and under all conditions tested the liver accounted for a surprisingly high proportion of the total. Clearly, however, all stimuli were relatively severe, so that our results may demonstrate the potential for hepatic gene expression rather than what is achieved under less severe stimulation. For a given stimulus, there was a continuous decline ofthe proportion of hepatic EPO mRNA with increasing age, resulting in a "shift" of the predominance from liver to kidneys between three and four weeks. This shift was not due to a reduction in the total amount of EPO mRNA in the liver, but rather resulted from a greater increase in the total amount of EPO mRNA in the kidneys (Fig. 4 B) . When organ weight is taken into consideration, it is evident that the concentration of EPO mRNA per gram liver tissue decreased with increasing age of the animals, whereas the converse was true for renal EPO mRNA concentrations (Table II) . Recently, EPO gene expression was demonstrated by in situ hybridization in parenchymal as well as nonparenchymal murine liver cells (21) . However, the type and size ofthe hepatic cell populations producing EPO at different stages ofdevelopment are yet unknown. Ifthe number of hepatic EPO-producing cells increases in proportion to liver growth, than the results suggest that for a given stimulus these cells produce progressively less EPO after about two weeks of life (Table II) . Alternatively, the findings may indicate that subpopulations of hepatic cells that produce EPO proliferate less rapidly than the majority of liver cells. In the kidneys EPO mRNA increased out of proportion to the increase in organ weight during development (Table II) . Interestingly, in this regard, in adult mice with varying degrees of anemia, the modulation of EPO mRNA has been shown to reflect variations in the number of cells in the renal cortical interstitium that express the EPO gene, with individual cells expressing the gene in an essentially all-or-none manner (22) . Whether the age-dependent increase in EPO mRNA also results from an increasing recruitment of cells remains to be investigated.
When considering the significance of the accumulation of EPO mRNA, an important question arises with regard to the efficiency with which EPO mRNA in liver and kidneys is translated to achieve a rise in serum hormone concentrations under different stimuli and at different stages of development. If one assumes that the distribution volume for EPO, that has been shown in adult rats to correspond to plasma volume (23) , is proportional to body weight, it appears justifiable to compare serum EPO levels with the total amount of EPO mRNA, i.e., the sum of renal and hepatic EPO mRNA, after it has been normalized by body weight. At each age level, this comparison revealed significant linear relationships (Fig. 6) , a result in keeping with the view that mRNA accumulation is the major control mechanism of EPO formation. Interestingly, however, the slope of this relationship increases about ninefold during development. Thus serum EPO levels at a given stimulus increased with age ( Fig. 1) , an observation in accordance with previous studies (2, 5, 10, 24, 25) , although the total amount of EPO mRNA when normalized for body weight was either constant or even declined with age (Table III) .
This age-dependent change in the relationship between EPO mRNA and the circulating hormone concentrations could arise by several mechanisms which the present study cannot clearly differentiate. Age-dependent alterations in both EPO production and metabolism, e.g., a decrease in distribution volume or clearance rate of the hormone are possible. With regard to EPO clearance rate some evidence has in fact recently been provided in humans that the halflife time ofEPO in neonates (26) is shorter than that in adults (27, 28) . On the other hand, the fact that the increase in the ratio between serum EPO levels and EPO mRNA coincides with the shifting of EPO gene expression from liver to kidneys, raises the question whether the translational efficiency in the liver is less than that in the kidneys, or whether a proportion of the newly synthesized hormone in the liver cannot enter the systemic circulation, since the liver is probably a major site of EPO clearance. Interestingly in this regard, no EPO was detected by Fried et al. (29) or Caro et al. (25) by bioassay for EPO in liver extracts of hypoxic newborn and developing rats; and Clemons et al., using a radioimmunoassay, found less EPO in the liver than in the kidneys ofhypoxic rats as early as two days after birth (24) .
Furthermore, although the age dependence ofthe effect ofbilateral nephrectomy on EPO formation shown by others (2, 5, 6, 10) is completely in accordance with the shift of EPO mRNA accumulation as observed in this study, a putative discrepancy appears to arise with regard to the quantitative contribution of the liver; while we found more than 30% of total EPO mRNA in the livers of adult rats (Fig. 4, Table III ), several studies showed that serum EPO levels after bilateral nephrectomy are reduced to -10-15% (1-3, 30) . To further investigate the cause of this difference we measured EPO mRNA accumulation in the livers in a separate group of bilaterally nephrectomized rats.
Interestingly, as shown in Fig. 5 , the amount of hepatic EPO mRNA in the nephrectomized animals was significantly reduced to -55%. This suggests that, due to an inhibition of EPO gene expression in the liver, studies in nephrectomized animals may have underestimated the contribution ofthe liver to EPO formation. Furthermore, since serum EPO levels after nephrectomy were only slightly more reduced than the total amount of EPO mRNA, it appears unlikely that the relationship between EPO mRNA and effective EPO production rate in the liver is generally much lower than in the kidneys. Thus the disproportionality between EPO mRNA and serum EPO levels during development is probably not primarily due to a switch in the site of production.
In conclusion, this study shows that: (a) despite a markedly increasing responsiveness of developing rats in terms of serum EPO levels under hypoxia, the amount of EPO mRNA, when related to body weight, is rather constant or even decreasing during development; (b) the liver contributes more than 50% to the total amount of EPO mRNA for up to four weeks of life; and (c) in adult animals the contribution of the liver under strong stimulation is more significant than previously recognized.
